Checkpoint Therapeutics (CKPT) Financials

$4.26

$0.00 (0.00%)

As on 30-May-2025 16:00EDT

Market cap

$371 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

22.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	--	0.04	0.10	0.19	0.27	1.07
Cost of Revenue	17.46	--	43.57	49.83	48.45	16.35
Gross Profit	8.50	0.04	-43.46	-49.63	0.27	1.07
Operating Expenses	56.42	56.22	52.25	58.53	56.99	24.27
Operating Profit (EBIT)	-56.38	-56.17	-52.15	-58.33	-56.72	-23.20
Other Income	--	--	--	--	0.05	0.12
Profit before Tax	-56.51	-56.24	-51.85	-62.62	-56.67	-23.08
Provision for Tax	0.04	-56.24	-0.17	4.29	-0.05	-0.12
Profit after Tax (Net Income)	-56.51	-56.24	-51.85	-66.92	-56.62	-22.96
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-56.67	-23.08

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	16.30	-12.63	-13.05	-19.48	29.75	35.38
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	20.30	17.20	7.22
Current Liabilities	17.87	20.10	18.43	32.77	25.98	7.22
Total Liabilities	52.03	7.47	5.38	13.29	55.73	42.60

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	--	--	--	--	--	--
Current Assets	34.16	7.47	5.38	13.29	55.73	42.60
Total Assets	52.03	7.47	5.38	13.29	55.73	42.60
Total Debt*	--	--	--	--	--	--
Net Current Assets	16.30	-12.63	-13.05	-19.48	29.75	35.38

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-31.10	-47.59	-57.55	-26.31	-16.55
Cash Flow from Investing Activities	--	--	--	--	--	--
Cash from Financing Activities	--	32.78	40.45	14.89	40.27	31.25
Net Cash Inflow / Outflow	--	--	--	--	13.96	14.70

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-1.32	-1.42	-1.90	-6.51	-7.21	-4.07
Cash EPS ($)	--	-1.42	-1.90	-6.51	-7.21	-4.07
Adjusted Book Value ($)	--	--	--	--	3.79	6.27
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.78	-1.74	-5.59	-3.35	-2.93
Free Cash Flow per Share ($)	--	-0.78	-1.74	-5.59	-3.35	-2.93

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	438.14	318.76	-1,304.00	-173.87	-84.69
ROE (%)	--	438.14	318.76	-1,304.00	-173.87	-84.69
ROA (%)	-131.06	-875.40	-555.46	-193.91	-115.16	-66.02
EBIT Margin (%)	--	--	-50,792.13	-32,700.00	-21,165.30	-2,170.35
Net Margin (%)	--	-137,170.73	-50,336.89	-34,851.56	-17,637.69	-1,931.12
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	--	-0.60	-0.46	-0.28	-0.75	-0.37
EBIT Growth (%)	45.85	--	16.67	-10.69	-144.49	6.64
Net Profit Growth (%)	-8.01	-8.47	22.52	-18.19	-146.58	6.58
EPS Growth (%)	44.19	0.25	0.71	0.10	-0.77	0.16
Book Value Growth (%)	187.51	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-2.26	-1.21	-0.79	-0.43	-0.65
Price / Book Value	22.75	-10.06	-4.79	-2.70	0.82	0.42
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.54	-2.14	-1.10	-0.69	0.53	1.11
Close Price ($)	4.04	3.20	2.29	5.11	31.10	26.50
High Price ($)	4.50	4.50	8.15	32.71	53.76	45.00
Low Price ($)	1.38	1.38	1.30	3.56	22.20	10.50
Market Cap ($ Cr)	370.71	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	1.91	0.37	0.29	0.41	2.14	5.90
Quick Ratio	1.91	--	--	0.41	--	5.90
Interest Coverage	--	--	--	-14.63	-1,070.25	--

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	--	--	--	38.02	6.34	1.87
Asset Turnover	--	0.01	0.01	0.01	0.01	0.03
Receivable days	--	--	258.87	85.61	25.21	7.86
Inventory Days	--	--	0.00	0.00	0.00	0.00
Payable days	--	--	75.89	101.43	73.79	72.78
Cash Conversion Cycle	--	--	182.97	-15.83	-48.57	-64.93

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.